CJC-1295 / Ipamorelin Sublingual Strips feature a combined formulation of CJC-1295 (500 mcg per strip) and Ipamorelin (500 mcg per strip) in a fast-dissolving format, developed to support preclinical research into peptide stability, compound pairing, and controlled delivery presentation within laboratory environments.
CJC-1295 is a synthetic growth hormone–releasing hormone (GHRH) analog, while Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, these peptides have been referenced in scientific literature and examined in non-clinical research models for their involvement in growth hormone signaling pathways, receptor interaction dynamics, and endocrine response frameworks.
The sublingual strip format provides a consistent, low-mess presentation designed for standardized handling and repeatable study protocols across controlled research settings.
FOR RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. This product has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Bodily introduction into humans or animals is strictly prohibited by law.
Alpha Biomed is not a compounding pharmacy or chemical compounding facility as defined under 503a of the federal food, drug, and cosmetic act. Alpha Biomed is not an outsourcing facility as defined under 503b of the federal food, drug, and cosmetic act.
Choosing a selection results in a full page refresh.
